# Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream

> **NCT01021787** · PHASE4 · COMPLETED · sponsor: **Loreal USA** · enrollment: 26 (actual)

## Conditions studied

- Sunburn

## Interventions

- **DRUG:** Titanium dioxide

## Key facts

- **NCT ID:** NCT01021787
- **Lead sponsor:** Loreal USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2011-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021787, "Dermal Penetration of the Titanium Dioxide in Anthelios SX SPF40 Cream". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01021787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*